Neurology

Discussion in 'Valeant Pharmaceuticals' started by anonymous, Sep 22, 2017 at 7:24 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Yep.
     

  2. anonymous

    anonymous Guest

    Stay away! Migranal is tanking and adding to the portfolio appears to be on hold. This contract could end any minute.
     
  3. anonymous

    anonymous Guest

    How many Reps do you have nationally?
     
  4. anonymous

    anonymous Guest

    A little over 30 but that could be declining soon to either folks jumping off a sinking ship or the contract being cut short due to poor performance.
     
  5. anonymous

    anonymous Guest

    Surprise T/C this Wednesday afternoon looks suspicious. Could be a restructure call or contract cancelled call. Have a contingency plan folks.
     
  6. anonymous

    anonymous Guest

    A whole lot of nothing on the t/c. A whole lot of nothing going on with this division. Lower the objective. Leadership is out of its collective mind if they think Migranal will grow in a CGRP dominated migraine market.
     
  7. anonymous

    anonymous Guest

    Anyone ever heard of Eversana Life Science Services LLC? This came out of nowhere. Bye, bye Alamo. Hello unknown or unemployment.
     
  8. anonymous

    anonymous Guest

    Many reps not feeling comfortable about the move to Eversana. Not a lot of clear information being given. Hmm.
     
  9. anonymous

    anonymous Guest

    You know this division is over when your best reps are leaving and reps are openly talking about looking for new jobs at national meetings.
     
  10. anonymous

    anonymous Guest

    Neversana is getting ever smaller while Management's pets are booking to Bausch & Lomb. Neurology is looking mighty weak now.
     
  11. anonymous

    anonymous Guest

    That happened quite a while ago in the North thanks to their manager.
     
  12. anonymous

    anonymous Guest

    That person has a highly flawed and highly inflated view of their management skills considering most of that original team left for much bigger and better. LOL!!!
     
  13. anonymous

    anonymous Guest

    It's amazing how successful a rep can be when they lower the objective to something reasonable. Event vacant territories can have success. LOL!
     
  14. anonymous

    anonymous Guest

    The sad thing is Migranal is so obnoxiously overpriced that even if the sales force is selling less scripts than before, the company is still making a lot of money off of it. The sales reps may not make a lot of money off it but BHC is. Pathetic.
     
  15. anonymous

    anonymous Guest

    Neurology was never that strong here. That's why most of the original reps that started hear a couple years ago found much better paying jobs.